Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fluoxetine hydrochloride
Cat. No.:
OB0225LY-0376
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Fluoxetine hydrochloride is a selective 5-HT reuptake inhibitor that affects neurotransmission.
Synonym:
Fluoxetine HCl; LY-110140; Lilly110140; 56296-78-7; Fluoxetine Hcl; 59333-67-4; Prozac; Sarafem; Fluoxeren; Adofen; Fluctin; Lovan; Fontex; Foxetin
CAS No.:
56296-78-7
Compound CID:
62857
Formula:
C17H19ClF3NO
Formula Weight:
345.787
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fluoxetine hydrochloride can be used to study mechanisms related to depression and anxiety or play an important role in neurobiological experiments.
Library Information
Targets:
G protein-coupled receptors (GPCRs); Monoamine transporters
Receptors:
5-HT; Serotonin transporter; Sert (Sodium-dependent)
Pathways:
Neuronal signaling; Autophagy; GPCR/G protein
Plate Number:
AOCL-5
Plate Location:
g11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 144.6 mM
Water Max Solubility:
3.5 mg/mL; 10 mM
